ArticleCell reports2018

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.

Liya Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.